Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Woluwe-Saint-Lambert
Clinical trial register · Belgium

Clinical Trials in Woluwe-Saint-Lambert, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Belgium and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3058 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:19 UTC
3058
Studies in scope
all four open statuses
1727
Recruiting now
open to new participants
508
Lead sponsors
across recruiting studies
Top sites
Leuven 1274 Brussels 1116 Ghent 1031 Liège 562 Edegem 442
Narrow the registerReset
Recruitment status
Phase
Site location
Leuven1274 Brussels1116 Ghent1031 Liège562 Edegem442 Antwerp292 Bruges263 Roeselare249 Hasselt214 Aalst185 Kortrijk183 Charleroi175 Genk174 Anderlecht166 Yvoir151 Namur139 Jette129 Sint-Niklaas117 Bonheiden101 Wilrijk75 Brasschaat72 Mechelen61 La Louvière60 Woluwe-Saint-Lambert57 Ottignies48 Haine-Saint-Paul43 Mons40 Gilly30 Dendermonde24 Diepenbeek23 Ostend20 Turnhout20 Merksem19 Alken17 Overpelt15 Libramont15 Ieper13 Louvain-la-Neuve12 Auderghem12 Tournai11 Tienen11 Herentals11 Verviers11 Libramont-Chevigny11 Lodelinsart9 Bouge9 Erpent9 Kluisbergen8 Eeklo7 Deurne7 Ottignies-Louvain-la-Neuve7 Geel7 Ronse6 Arlon6 Melsbroek6 Tongeren5 Boussu5 Haine Saint Paul La Louviere5 Pellenberg5 Rumst5 Gozée5 Oudenaarde4 Gent (Ghent)4 De Haan4 Maldegem4 Merchtem3 Kortenberg3 Machelen3 Brussel (Bruxelles)3 Multiple Locations3 Vilvoorde3 Deinze3 Heusden-Zolder3 Sint-Truiden3 Many Locations3 Loverval3 Sint-Martens-Latem3 Mont-godinne3 Belgium3 Tinlot3 Hornu3 Zottegem3 Haine-St-Paul2 Saint-Nicolas2 Knokke2 Herstal2 Lanaken2 Assebroek2 Bornem2 Laken2 Waregem2 Sart Tilman2 Bilzen2 Oisquercq2 Maaseik2 Woluwé-Saint-Lambert2 Brugge (Bruges)2 Melle2 Montegnée2 Linkebeek2 Lier2 Huy2 Jolimont2 Roeselaere2 Saint-Servais2 Gosselies2 Anderlecht/Brussels-Capital2 Heverlee1 Lokeren1 Sovet1 Geraardsbergen1 Woluwe-St. Lambert1 Zoersel1 Waterschei-Zwartberg1 Sint-Gillis-Dendermonde1 Torhout1 Merksem (Antwerpen)1 Steenokkerzeel1 Gesves1 Heule1 Aartselaar1 Marche-en-Famenne1 Schoten1 Stavelot1 Berchem1 Brussels (Bruxelles)1 Saint-Symphorien1 Seneffe1 Wavre1 Braine-l'Alleud1 Mouscron1 Zürich1 Bree1 Mol1 St-Lambrechts-Woluwe1 Lueven1 Sint-Pieters-Leeuw1 Dinant1 Leige1 Menen1 Rosières1 Ixelles-Elsene1 Brussles1 Ath1 Woluwe-Saint-Pierre - Sint-Pieters-Woluwe1 Ruddershove1 Therasse 11 Lennik1 Beerzel1 Beuzet1 Noirefontaine1 Aye1 Stene1 Neder-Over-Heembeek1 Malmedy1 Baudour1 Ciney1 Esneux1 Louvière1 Antwerpen1 Heist-op-den-Berg1 Duffel1 Flemish Brabant1 Gent Oost-Vlaanderen1 Herk-de-Stad1 Keerbergen1 Sint-Agatha-Berchem1 Aubel1 Chaudfontaine1 Zwijnaarde1 Beernem1 Boechout1 Lede1 Rekem1 Diest1 Peer1 Woluwe1 Bruxelles - Brussel1 Gistoux1 Godinne1 Wondelgem1 Brussel/ Brussels/bruxelles1 Boutersem1 Wommelgem1 Edegem/Antwerpen1 Gent/Oost-Vlaanderen1 Leuven/Vlaams-Brabant1 Ninove1 Alleur1 Seraing1 Chenée1 Zwalm1 Leper1 Wetteren1 Mont Gaston1 Koekelberg/Brussel (Bruxelles)1 Godinne-mont1 Kraainem1 Wuerzburg1 Kontich1 Mont-Godinne Yvoir1 Wilrijk - Antwerpen1 Malle1 Liége1 Thuin1 Limbourg1
All 206 locations
Target enrolment
to

Trials with a site in Woluwe-Saint-Lambert

57 of 3058 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Belgium
Start
Recruiting
Solstice Oncology, Inc.
Phase 2
100
Anderlecht, Bonheiden, Ghent, Leuven, Liège, Ostend, Woluwe-Saint-Lambert
2026-11-30
Recruiting
Corbus Pharmaceuticals Inc.
Phase 3
260
Edegem, Ghent, Leuven, Sint-Niklaas, Woluwe-Saint-Lambert
2026-09-29
Recruiting
Incyte Corporation
Phase 3
426
Anderlecht, Brussels, Leuven, Liège, Roeselare, Woluwe-Saint-Lambert
2026-09-08
Recruiting
Université Catholique de Louvain
Not applicable
225
Woluwe-Saint-Lambert
2026-09
Recruiting
Prilenia
Phase 3
400
Anderlecht, Woluwe-Saint-Lambert
2026-07-01
Recruiting
Jules Bordet Institute
Not applicable
31
Anderlecht, Brussels, Woluwe-Saint-Lambert
2026-06-03
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals
Phase 3
460
Woluwe-Saint-Lambert, Roeselare
2026-05-27
Recruiting
Incyte Corporation
Phase 2
60
Brussels, Woluwe-Saint-Lambert
2026-05-20
Recruiting
Ipsen
Phase 3
350
Brussels, Woluwe-Saint-Lambert, Edegem, Ghent, Leuven
2026-05-14
Active, closed
Factors Determining the Rate of Adoption of Pharmaceutical Recommendations by Patients in Primary Care Following a Medication Review by a Pharmacist
NCT07606716Polypharmacy (People Under Treatment With 5 or More Drugs), Polypharmacy, Decision-making, Medication Review
Université Catholique de Louvain
Not applicable
123
Woluwe-Saint-Lambert
2026-01-12
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Edegem, Haine-Saint-Paul, Leuven, Sint-Niklaas, Woluwe-Saint-Lambert
2025-12-03
Recruiting
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Not applicable
20
Woluwe-Saint-Lambert
2025-11-18
Recruiting
Incyte Corporation
Phase 3
250
Brussels, Ghent, Leuven, Woluwe-Saint-Lambert
2025-11-13
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Brussels, Woluwe-Saint-Lambert, Kortrijk, Liège, Charleroi
2025-11-03
Recruiting
BioNTech SE
Phase 3
558
Bonheiden, Brussels, Gilly, Leuven, Woluwe-Saint-Lambert
2025-10-30
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Woluwe-Saint-Lambert, Maldegem, Ghent
2025-09-22
Recruiting
HOPE Against Cancer Recurrence in HCC
NCT06717919Liver Transplantation, HCC, Oncological Outcomes
Philipp Dutkowski
Phase 4
220
Leuven, Woluwe-Saint-Lambert
2025-08-01
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
Exelixis
Phase 2/3
440
Brussels, Edegem, Leuven, Woluwe-Saint-Lambert
2025-07-21
Recruiting
MedSIR
Phase 2
200
Brasschaat, Ghent, Mons, Woluwe-Saint-Lambert
2025-06-30
Active, closed
Incyte Corporation
Phase 3
9
Bruges, Godinne-mont, Leuven, Liège, Roeselare, Woluwe-Saint-Lambert
2025-06-04
Recruiting
Daiichi Sankyo
Phase 3
582
Ghent, Leuven, Liège, Namur, Woluwe-Saint-Lambert
2025-03-19
Recruiting
Bayer
Phase 1
36
Edegem, Woluwe-Saint-Lambert, Ottignies, Liège
2025-03-12
Recruiting
Incyte Corporation
Phase 3
600
Brussels, Ghent, Liège, Loverval, Woluwe-Saint-Lambert
2025-02-28
Recruiting
BioNTech SE
Phase 2/3
1,580
Ghent, Leuven, Mons, Roeselare, Sint-Niklaas, Woluwe-Saint-Lambert
2025-01-07
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Endometrioid Ovarian Cancer
TORL Biotherapeutics, LLC
Phase 2
230
Edegem, Woluwe-Saint-Lambert, Leuven, Liège
2024-11-20
Active, closed
Eli Lilly and Company
Phase 2
45
Ghent, Leuven, Woluwe-Saint-Lambert
2024-10-25
Active, closed
Incyte Corporation
Phase 3
346
Bruges, Ghent, Gilly, Liège, Woluwe-Saint-Lambert
2024-10-10
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Woluwe-Saint-Lambert
2024-10-09
Recruiting
Lakefront Biotherapeutics NV
Phase 3
546
Edegem, Leuven, Liège, Roeselare, Woluwe-Saint-Lambert
2024-09-09
Recruiting
Eli Lilly and Company
Phase 3
510
Erpent, Ghent, Woluwe-Saint-Lambert
2024-04-29
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Sanofi
Phase 3
2,500
Bruges, Brussels, Ghent, Leuven, Liège, Overpelt, Woluwe-Saint-Lambert
2024-04-16
Active, closed
argenx
Observational
413
Brussels, Edegem, Ghent, Jette, Leuven, Liège, Woluwe-Saint-Lambert
2023-11-29
Active, closed
Incyte Corporation
Phase 3
467
Brussel/ Brussels/bruxelles, Ghent, Liège, Woluwe-Saint-Lambert
2023-11-29
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Pharmaceuticals, Inc.
Phase 3
510
Edegem, Wilrijk, Woluwe-Saint-Lambert, Charleroi, Leuven
2023-11-16
Recruiting
Université Catholique de Louvain
Observational
300
Woluwe-Saint-Lambert
2023-10-07
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Bonheiden, Ghent, Roeselare, Liège, Lodelinsart, Woluwe-Saint-Lambert
2023-07-06
Recruiting
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Not applicable
34
Woluwe-Saint-Lambert
2023-07-01
Active, closed
Servier Affaires Médicales
Phase 3
299
Brussels, Ghent, Leuven, Woluwe-Saint-Lambert
2023-05-03
Active, closed
Pfizer
Phase 3
624
Edegem, Woluwe-Saint-Lambert, Gilly, Leuven, Liège
2023-03-03
Active, closed
Klus Pharma Inc.
Phase 2
240
Brasschaat, Charleroi, Woluwe-Saint-Lambert
2023-01-17
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Brussels, Edegem, Ghent, Leuven, Woluwe-Saint-Lambert
2022-11-23
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Brussels, Ghent, Leuven, Woluwe-Saint-Lambert
2022-11-08
Active, closed
AZ Sint-Jan AV
Not applicable
170
Edegem, Lodelinsart, Hasselt, Liège, Ghent, Leuven, Woluwe-Saint-Lambert, Ottignies-Louvain-la-Neuve
2022-09-01
Recruiting
Stemline Therapeutics, Inc.
Phase 1/2
73
Edegem, Leuven, Woluwe-Saint-Lambert
2022-08-31
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765Hip Fractures, Myocardial Injury
Population Health Research Institute
Not applicable
1,100
Woluwe-Saint-Lambert
2021-11-22
Active, closed
Bioverativ, a Sanofi company
Phase 3
261
Woluwe-Saint-Lambert
2021-02-23
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Edegem, Leuven, Liège, Woluwe-Saint-Lambert
2021-02-01
Active, closed
argenx
Phase 2
229
Edegem, Leuven, Liège, Woluwe-Saint-Lambert
2020-09-18
Recruiting
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
NCT04263038Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases
Drahomir Aujesky
Phase 4
276
Woluwe-Saint-Lambert, Liège
2020-05-15
Active, closed
AbbVie
Phase 3
1,533
Jette, Woluwe-Saint-Lambert, Ghent, Loverval
2018-08-09
Active, closed
Persona Partial Knee Clinical Outcomes Study
NCT03034811Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures
Zimmer Biomet
Not applicable
757
Woluwe-Saint-Lambert
2017-02-08
Active, closed
AbbVie
Phase 3
443
Jette, Woluwe-Saint-Lambert, Ghent, Bruges
2017-02-02
Active, closed
Avenir® Cemented Hip Stem - PMCF
NCT03396224Primary Osteoarthritis, Post-Traumatic Osteoarthritis of Hip, Femoral Neck Fractures, Femoral Head Necrosis
Zimmer Biomet
Observational
100
Woluwe-Saint-Lambert
2015-11-18
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Brussels, Edegem, Ghent, Leuven, Liège, Woluwe-Saint-Lambert
2013-03-18
Rows per page Showing 1–57 of 57
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Belgian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-belgium/city/woluwe-saint-lambert

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Belgium and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,058 studies in total at the last sync on 15 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 57 of those studies with a site in Woluwe-Saint-Lambert.

How many clinical trials are recruiting in Woluwe-Saint-Lambert?

33 of the 57 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 24 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Woluwe-Saint-Lambert), 57 studies
PhaseStudiesRecruitingShare
Phase 3301552.6%
Not applicable8514%
Phase 28514%
Observational427%
Phase 1213.5%
Phase 2/3223.5%
Phase 4223.5%
Phase 1/2111.8%

Most active sponsors

Lead sponsors with the most studies (Woluwe-Saint-Lambert)
Lead sponsorStudiesRecruiting
Incyte Corporation74
AbbVie40
Université Catholique de Louvain32
argenx20
BioNTech SE22
Cliniques universitaires Saint-Luc- Université Catholique de Louvain22
Eli Lilly and Company21
Janssen Research & Development, LLC22
Novartis Pharmaceuticals21
Olema Pharmaceuticals, Inc.21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.